k-aro event



Platinum Sponsors

  • More inforrmation will follow in due course.

  • More inforrmation will follow in due course.

  • BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them.


  • More inforrmation will follow in due course.

  • More inforrmation will follow in due course.

Gold Sponsor

  • More inforrmation will follow in due course.

Bronce Sponsors

  • More information will follow in due course.

  • Prelude’s approach is to apply its expertise in cancer biology and medicinal chemistry to identify targetable intervention points in cancer signaling pathways. Once a target is identified, Prelude employs its internal discovery engine to design and synthesize novel inhibitors or degraders. Our pipeline consists of highly differentiated molecules that were optimized to block key oncogenic pathways in hematological malignancies and solid tumors.


Copper Sponsor

MSD Sharp & Dohme GmbH

We would like to thank AbbVie Deutschland GmbH & Co. KG, AstraZeneca GmbH, BeiGene Germany GmbH, Janssen-Cilag GmbH and Lilly Deutschland GmbH for their kind support of this meeting with Sponsorship Package A (Plantin Sponsors | €70,000 each) and Roche Pharma AG with Sponsorship Package B (Gold Sponsor | €40,000). Bristol-Myers Squibb GmbH & Co. KGaA and Prelude Therapeutics, Inc. are supporting the conference with Sponsorship Package D (Bronze Sponsors | €10.000 each), MSD Sharp & Dohme GmbH is contributing €5,000 (Copper Sponsor) to the International DCLLSG workshop. The sponsors' contributions will be used for event management, website, venue, catering and working lunches, hotel accommodation, travel expenses (of speakers, moderators, strategy committee members), video reports, certification, insurance, printing materials and technical equipment. The organiser, the scientific director and the speakers confirm that the event is product-neutral. Any conflicts of interest of the speakers will be disclosed prior to the presentation.